In parallel, the SURMOUNT trials, which focused on individuals with obesity with or without diabetes, revealed substantial and sustained weight loss that exceeded outcomes typically achieved with existing pharmacologic options
GLP-1 agonists (semaglutide, tirzepatide) are not controlled substances, so they arent subject to DEA telehealth restrictions
There are no established drug interactions between creatine and common diabetes medications such as metformin, insulin, GLP-1 receptor agonists, or SGLT2 inhibitors
Supplementary material The Supplementary Material for this article can be found online at: References 1 AhangarN.NaderiM.NorooziA.GhasemiM.ZamaniE.ShakiF
Wellaholics expert team prioritises honest assessments to ensure the technology is only applied where it will be genuinely effective
The design of formularies influences which drugs people can get through their insurance, whether patients are subject to utilization management rules before they can access a drug, and what patient out-of-pocket costs are
